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Aim We sought to determine achievement of lipid targets according to cur-
rent European guidelines (low-density lipoprotein cholesterol [LDL-C]
≤70mg/dL) in patients with stable coronary heart disease (CHD) with or
without lipid-lowering therapy (LLT), in the French cohort of the Dyslipid-
emia International Study IICHD (DYSIS IICHD).
Methods DYSIS IICHD was a multicentre observational cross-sectional
study conducted from July 2013 to October 2014 in 27 centres in France.
Adults with stable CHD (defined as ≥1 of the following: >50% stenosis on
coronary angiography or computed tomography, prior percutaneous coronary
intervention, prior coronary bypass graft, history of ACS >3 months previ-
ously) and a fasting lipid profile done within the previous 12 months were
consecutively enrolled. Eligible patients had to be on LLT for ≥3 months or
taking no LLT.
Results A total of 436 CHD patients were enrolled. Of the 424 patients
(97.2%) on LLT, 91.5% were on statin treatment at the moment of inclusion
(mean±SD dose calculated in atorvastatin 27±23mg/day). Non-statin LLT was
used in 17.7% patients (79.2% were on a cholesterol-absorption inhibitor).
Mean±SD LDL-C was 87.4±30.5mg/dL, 28.4% achieved LDL-C<70mg/dL,
and 67.7% had an LDL-C<100mg/dL (Table).
Conclusions These observational data from contemporary clinical practice
in France indicate suboptimal lipid control, with over two-thirds of high-risk
CHD patients failing to achieve the LDL-C target despite taking LLT, and a
large difference between mean value and target LDL-C. More-intensive treat-
ment is required to optimize achievement of lipid goals in CHD.
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Background Coronary artery disease is the leading cause of cardiovascular
diseases, which remains the major cause of death for women. Prevention,
screening and diagnosis tend to be performed at late stages and less fre-
quently, and treatments are not optimal in women. The consequences of a tar-
geted screening for myocardial ischemia in women at risk have not yet been
studied.
Methods We conducted a prospective observational study with retrospec-
tive data collection based on a cohort of female patients at cardiovascular risk,
with or without symptoms, who benefited from a non-invasive diagnostic test,
offered through the care pathway “Heart, arteries and women” from the Lille
University hospital of Lille, between January 1st, 2013 and June 31st, 2014.
The objective was to determine the relevance of this screening and which fac-
tors would help in targeting women more efficiently.
Results The screening gave a positive result in for 15.7% of the
287 women included. 
Among the 30 women that benefited from a coronarography, 72% had no
obstructive coronary artery disease. The independent predictive factors of a
positive screening were a menopause since more than 5 years (OR=4.17;
p=0.001), an HDL-c ≤0.5 g/dL (OR=2.45; p=0.023) and an IMC ≥32
(OR=4.58; p=0.0001). A clinical coronary score based on these factors was
developed to target the screening (AUC 0.765). The symptoms, presents in
half of the patients, were predictive of a positive screening (p=0.010) but were
mostly atypical. 
The classical cardiovascular risk scores were inefficient at predicting a cor-
onary artery disease (AUC 0.618 to 0.681). The positive screening had
resulted into a low rate of revascularization (17%) but in a significant increase
of in the prescription of statin (p=0.002), antiplatelet agents (p<0.0001) and
beta blockers (p=0.024).
Conclusion The screening for myocardial ischemia among selected women
at risk of cardiovascular diseases allows optimizing their care in secondary
prevention. 
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Introduction Coronary artery disease is a public health problem, whose
prognosis and management depend on the development of lesions, hence the
need to determine the profile of patients most at risk of developing major
lesions, as well as items that can influence their prognosis.
Objective The aim of our study is to identify the epidemiological profile
of patients treated for acute coronary syndrome or explored for effort angina
and have a documented three-vessel coronary disease. The second objective is
to identify mortality factors.
Method This is a descriptive study that examined patients records hospital-
ized for coronary artery disease during the period from Jan 2007 to Dec 2012
and who have a three vessel coronary disease. The mean of follow up is
4 years. 
Results During the period, 365 patients were hospitalized. This is 23%
women and 77% of men (3.5 /1); the average age was 64 years for men VS
69 years for women (p<0.001). The reason for hospitalization was 44% of
STEMI, 33% NSTEMI, 23% of effort angina. Diabetic patients accounted for
49%, 66% women vs 47% of men (p=0.001). Hypertension is present in 60%
of patients. 34% of patients were smokers. Left ventricular function was








Age (years) 69±12 69±12 74±12
Men 80.0 79.7 91.7
ACS >3 months previously 70.0 70.0 66.7
Diabetes type 2 27.0 27.3 16.7
Chronic kidney disease 5.0 5.2 0
Lipid variables
LDL-C (mg/dL) 87.4±30.5 86.0±29.6 135.3±24.5**
LDL <70 mg/dL 28.4 29.2 0*
Distance to target 
of <70 mg/dL (mg/dL) 31.1±24.2 29.7±23.2 65.3±24.5**
LDL <100 mg/dL 67.7 69.3 8.3**
Data are mean±SD or %. *P<0.05; **P?0.0001 (LLT vs no LLT)
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impaired in 12% of cases. 213 patients (58%) had CABG (66% had diabetes
(p<0.0001). 65 patients had an Angioplasty (13% of diabetics (p=0.01)) and
87 medical treatment alone. 52 patients died; These 32 men and 20 women.
After the multivariate study, it was found that treatment with angioplasty was
a factor of persistent angina after revascularization (OR=12). Diabetes
(OR=3.27), and female gender (2.17) are mortality factors, regardless of the
therapeutic decision. After revascularization, excess mortality was found in
the angioplasty alone group (OR=6) diabetics (3.3) and females (2.5).
Conclusion The multiple risk factor is a factor favoring triple vessel
lesions. Mortality is higher in patients treated with angioplasty and even more
so that they are diabetic women.
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Aims To assess arterial stiffness (AS) markers in patients with coronary
artery disease (CAD) and concomitant type 2 diabetes mellitus (T2DM). 
Methods We examined 62 patients with CAD (21 males, age 60.5±4.7
years). All patients were divided into 2 groups: the 1st (n=32) – patients with
concomitant T2DM, the 2nd (n=30) – without T2DM. The HbA1c was <7.5%.
The control group includes 20 healthy volunteers. 
In all patients were determined the lipid metabolism. 
We conducted coronary angiography, ultrasound of the carotid arteries
(CA) with determination of intima-media thickness (IMT) of the common
carotid artery (CCA), AS was measured as carotid-femoral pulse wave
velocity (cf-PWV) on the rheovasography, ankle-brachial index (ABI). 
Results According to coronary angiography among 1st group of patients in
75% cases registered atherosclerotic lesion (AL) of two or more coronary
arteries, in the 2nd – at 70% cases registered AL of one coronary arteries
(p<0.05). IMT-CCA values were significantly higher in the 1st group com-
pared with the 2nd group (1.34±0.12 vs 1.11±0.11, p<0.05). 
cf-PWV and ABI value also were higher in the 1st group (9.32±1.54 vs
7.53±0.91m/s and 1.51±0.08 vs 1.12±0.09 respectively). There were correla-
tions between cf-PWV and IMT-CCA (r=0.41, P=0.043), cf-PWV and ABI
(r=0.32, P=0.039), IMT-CCA and ABI (r=0.39, P=0.037). There were regis-
tered correlation between cf-PWV and extent of coronary atherosclerosis
(r=0.31, P=0.044) and between IMT-CCA and extent of coronary atheroscle-
rosis (r=0.32, P=0.045). IMT-CCA and cf-PWV were higher in diabetic
patients with hypertriglyceridemia (p<0.05).
Conclusion Determination of noninvasive indicators of AS, such as cf-
PWV, IMT-CCA and ABI, are necessary in the routine clinical practice for the
early diagnosis and prevention of vascular complications, including coronary
atherosclerosis in patients with T2DM. 
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Purpose Drug eluting stents represent a major advance in coronary revas-
cularization reducing neointimal hyperplasia. However, in-stent restenosis
(ISR) was not completely eradicated. The aim of our study was to determine
the frequency of the ISR, its angiographic and clinical patterns, the time to
onset and different predictors of occurrence. 
Methods We collected retrospectively clinical and angiographic data of
749 patients hospitalized in the cardiology department of the Military Hospital
of Tunis between January 2002 and June 2010 and who underwent percuta-
neous coronary intervention with drug-eluting stents in 1159 lesions. The
exclusion of patients without follow-up reduced the size of the population to
577 patients and 936 lesions.
Results The average age of our patients was 59.65±10 years. The preva-
lence of clinical ISR was 18.9% per patient and 15.9% per lesion. Its average
time to onset was 27.6±20 months. Acute coronary syndrome was the most
frequent clinical presentation (83.4%). The focal angiographic form was pre-
dominant (64%).
Predictors of ISR in univariate analysis were: dyslipidemia (p=0.001),
overweight (p=0.001), stenting of proximal left anterior descending artery
(p=0.002), severe calcifications (p=0.001), B2 and C lesions (p=0.001), reste-
nosis lesion (p=0.19), reference vessel diameter (p=0.003), minimal lumen
diameter (p=0.006), lesion length (p=0.02), sirolimus eluting stent (p=0.001).
Protective factors were: use of everolimus eluting stent (p=0.001) and infla-
tion pressure >16 atmospheres (p=0.022). Predictors in multivariate analysis
were: restenosis lesion (OR=32, p=0.012) and severe calcifications (OR=38,
p=0.016). Inflation pressure >16 atmospheres was a protective factor (OR=27,
p=0.017).
Conclusion The ISR remains a potential risk even with drug-eluting stents. 
A better understanding of its characteristics could provide solutions and
reduce its prevalence and complications.
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Background Elderly patients with acute ST-elevation myocardial infarc-
tion (STEMI) remain undertreated.
Purpose To evaluate the management of elderly STEMI patients treated in
a formal regional network of care.
Methods This prospective analysis, based on data from the ongoing
RESURCOR coronary emergency network, involved 6169 patients presenting
with an acute STEMI between 2002 and 2011 in the north French Alps. 
Patients were divided into age groups: <65, 65-74, 75-84 and ≥85 years.
Reperfusion rates, types, timing and adjunctive medications were compared.
The RESURCOR network advocates primary percutaneous coronary inter-
vention (PPCI) over fibrinolysis and bivalirudin over glycoprotein inhibitors
(GPI) in the elderly.
Results Lack of reperfusion therapy increased with age (Table).
The rate of fibrinolysis was higher than that for PPCI in younger patients
whereas the situation was reversed in elderly patients.
In patients who had PPCI, use of bivalirudin increased and GPI decreased
with age, system delays were similar.
Conclusion These regional French data indicate that elderly STEMI
patients receive appropriate management with timely delivered PPCI and
bivalirudin; however, a substantial proportion are still undertreated.
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